KRYS Return on Tangible Equity | Krystal Biotech, Inc.

Krystal Biotech, Inc. (KRYS) Return on Tangible Equity

2026-06-30: Return Tang Equity 17.77%.
2026-03-31: Return Tang Equity 17.63%.
2025-12-31: Return Tang Equity 16.80%.
2025-09-30: Return Tang Equity 17.48%.

Complete source-backed return tang equity history.

Available history: 2016-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	17.77%
2026-03-31	17.63%
2025-12-31	16.80%
2025-09-30	17.48%
2025-06-30	14.10%
2025-03-31	12.59%
2024-12-31	9.42%
2024-09-30	5.91%
2024-06-30	12.63%
2024-03-31	7.15%
2023-12-31	1.40%
2023-09-30	-3.94%
2023-06-30	-21.50%
2023-03-31	-27.64%
2022-12-31	-26.80%
2022-09-30	-23.99%
2022-06-30	-20.65%
2022-03-31	-18.91%
2021-12-31	-11.72%
2021-09-30	-14.24%
2021-06-30	-12.46%
2021-03-31	-9.90%
2020-12-31	-11.01%
2020-09-30	-9.00%
2020-06-30	-7.04%
2020-03-31	-10.24%
2019-12-31	-9.41%
2019-09-30	-8.40%
2019-06-30	-8.03%
2019-03-31	-11.74%
2018-12-31	-9.62%
2018-09-30	-16.40%
2018-06-30	-24.50%
2018-03-31	-20.20%
2017-12-31	-16.01%
2017-09-30	-14.25%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	16.80%
2024-12-31	9.42%
2023-12-31	1.40%
2022-12-31	-26.80%
2021-12-31	-11.72%
2020-12-31	-11.01%
2019-12-31	-9.41%
2018-12-31	-9.62%
2017-12-31	-16.01%
2016-12-31	-397.92%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
REPLIGEN CORP (RGEN)	United States	$10.755B	185.31
Kymera Therapeutics, Inc. (KYMR)	United States	$9.631B	-31.69
ImmunityBio, Inc. (IBRX)	United States	$9.157B	-9.29
BIO-TECHNE Corp (TECH)	United States	$11.379B	74.68
Twist Bioscience Corp (TWST)	United States	$11.540B	-47.21
Vaxcyte, Inc. (PCVX)	United States	$8.466B	-7.91
HALOZYME THERAPEUTICS, INC. (HALO)	United States	$13.083B	21.59
Immunovant, Inc. (IMVT)	United States	$7.028B	-14.78
NEUROCRINE BIOSCIENCES INC (NBIX)	United States	$14.131B	24.25
CG Oncology, Inc. (CGON)	United States	$6.095B	-27.95